Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$5.56
-6.2%
$4.71
$1.53
$9.20
$348.57M2.46297,081 shs607,462 shs
Enhabit, Inc. stock logo
EHAB
Enhabit
$6.79
+2.0%
$9.34
$6.50
$10.91
$337.24M1.72487,376 shs664,789 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$2.92
-2.7%
$2.16
$1.37
$9.13
$113.02M0.99178,948 shs107,903 shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$3.50
-4.1%
$2.74
$0.13
$3.78
$325.70M0.021.23 million shs2.67 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-6.24%+11.65%+11.20%+227.06%+17.30%
Enhabit, Inc. stock logo
EHAB
Enhabit
+1.57%-3.69%-27.32%-11.53%-29.93%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-2.67%+2.82%+55.32%-14.12%-63.41%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-4.11%+11.82%+47.06%+62.04%+550.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
1.2987 of 5 stars
1.03.00.00.02.75.00.0
Enhabit, Inc. stock logo
EHAB
Enhabit
3.4289 of 5 stars
3.34.00.00.02.80.02.5
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.4789 of 5 stars
0.02.00.00.02.22.50.0
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
2.2441 of 5 stars
3.82.00.00.03.20.80.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
2.00
Hold$3.75-32.55% Downside
Enhabit, Inc. stock logo
EHAB
Enhabit
2.50
Moderate Buy$8.7528.87% Upside
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.00
N/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
3.50
Strong Buy$6.5085.71% Upside

Current Analyst Ratings Breakdown

Latest SERA, EHAB, AIRS, and TOI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
7/15/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/15/2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$7.00
(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$180.35M1.81$0.16 per share35.36$1.37 per share4.06
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.33$4.17 per share1.63$10.92 per share0.62
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$80K1,374.96N/AN/A$1.40 per share2.09
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$393.41M0.79N/AN/A$0.05 per share70.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$8.25M-$0.30N/AN/A-9.95%-15.01%-5.85%8/8/2025 (Estimated)
Enhabit, Inc. stock logo
EHAB
Enhabit
-$156.20M-$2.77N/A23.41N/A-13.43%2.02%0.94%8/5/2025 (Estimated)
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$32.90M-$0.94N/AN/AN/A-28,685.22%-51.35%-37.21%8/6/2025 (Estimated)
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$64.66M-$0.70N/AN/A-15.38%-445.02%-34.13%8/12/2025 (Estimated)

Latest SERA, EHAB, AIRS, and TOI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$0.13N/AN/AN/A$112.56 millionN/A
8/8/2025Q2 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$0.02N/AN/AN/A$45.59 millionN/A
8/6/2025Q2 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.21N/AN/AN/AN/AN/A
8/5/2025Q2 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.10N/AN/AN/A$263.39 millionN/A
5/14/2025Q1 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 million
5/14/2025Q1 2025
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/A-$0.18N/A-$0.21N/A$104.41 million
5/7/2025Q1 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.07$0.10+$0.03$0.35$266.11 million$259.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
0.90
0.57
0.57
Enhabit, Inc. stock logo
EHAB
Enhabit
0.82
1.49
1.49
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/A
2.02
2.02
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
14.58
1.79
1.59

Institutional Ownership

CompanyInstitutional Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
91.54%
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
54.64%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
36.86%

Insider Ownership

CompanyInsider Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
76.58%
Enhabit, Inc. stock logo
EHAB
Enhabit
3.40%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
13.50%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
8.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
24058.78 million13.77 millionOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,70050.64 million48.92 millionOptionable
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
12037.67 million32.59 millionOptionable
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
66089.23 million81.65 millionNot Optionable

Recent News About These Companies

Q2 Earnings Estimate for TOI Issued By B. Riley
B. Riley Begins Coverage on Oncology Institute (NASDAQ:TOI)
Oncology Institute (NASDAQ:TOI) Stock Rating Upgraded by B. Riley
Three weeks on, Kidwai’s sole MRI machine still not working

New MarketBeat Followers Over Time

Media Sentiment Over Time

AirSculpt Technologies stock logo

AirSculpt Technologies NASDAQ:AIRS

$5.56 -0.37 (-6.24%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$5.56 0.00 (0.00%)
As of 07/18/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Enhabit stock logo

Enhabit NYSE:EHAB

$6.79 +0.13 (+1.95%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$6.58 -0.21 (-3.15%)
As of 07/18/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Sera Prognostics stock logo

Sera Prognostics NASDAQ:SERA

$2.92 -0.08 (-2.67%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.92 0.00 (0.00%)
As of 07/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Oncology Institute stock logo

Oncology Institute NASDAQ:TOI

$3.50 -0.15 (-4.11%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.57 +0.07 (+2.00%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.